GWLL (Goldenwell Biotech) EPS without NRI: $0.00 (TTM As of Mar. 2026)


GWLL Goldenwell Biotech Inc GWLL
30 GF Score
Price $0.90
! 1 Warning Sign
View Full Analysis

What is Goldenwell Biotech EPS without NRI?

Goldenwell Biotech GWLL 30 EPS without NRI is $0.00 as of Mar. 2026. GuruFocus rates GWLL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,525 Consumer Packaged Goods companies, Goldenwell Biotech ranks better than 86.36% on this metric.

Goldenwell Biotech's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Goldenwell Biotech's EPS without NRI or its related term are showing as below:

GWLL' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0   Med: 26.8   Max: 53.6
Current: 53.6

GWLL's 3-Year EPS without NRI Growth Rate is ranked better than
86.36% of 1525 companies
in the Consumer Packaged Goods industry
Industry Median: 7.3 vs GWLL: 53.60

Goldenwell Biotech's EPS (Diluted) for the three months ended in Mar. 2026 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.00.

Goldenwell Biotech's EPS (Basic) for the three months ended in Mar. 2026 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.00.


Goldenwell Biotech  (OTCPK:GWLL) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Goldenwell Biotech EPS without NRI Related Terms


Goldenwell Biotech EPS without NRI Historical Data

* Premium members only.

The historical data trend for Goldenwell Biotech's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Goldenwell Biotech EPS without NRI Chart

Goldenwell Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial -0.00 -0.01 0.00 -0.00 -0.00

Goldenwell Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GWLL vs HAIN, LSF, BFNH: EPS without NRI Comparison

For the Packaged Foods subindustry, Goldenwell Biotech's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Goldenwell Biotech PE Ratio without NRI vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Goldenwell Biotech's PE Ratio without NRI falls into.


GWLL
30GF Score
Goldenwell Biotech Inc GWLL
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Goldenwell Biotech EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.00 mean?
Goldenwell Biotech (GWLL) has a EPS without NRI of $0.00 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Goldenwell Biotech and its competitors. According to the industry distribution chart, Goldenwell Biotech ranks #208 out of 1525 companies in the Consumer Packaged Goods industry, placing it in the top 13.6%.
Is Goldenwell Biotech's EPS without NRI too high?
Goldenwell Biotech's current EPS without NRI is $0.00. Based on the distribution chart, Goldenwell Biotech ranks #208 out of 1525 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Goldenwell Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Goldenwell Biotech's EPS without NRI compare to HAIN and LSF?
According to the Consumer Packaged Goods industry distribution chart, Goldenwell Biotech ranks #208 out of 1525 companies for EPS without NRI. This places Goldenwell Biotech in the top 14% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Consumer Packaged Goods company?
The median EPS without NRI among Consumer Packaged Goods companies is 7.30, based on 1,525 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Goldenwell Biotech and its competitors. For the Consumer Packaged Goods industry, the median EPS without NRI is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Goldenwell Biotech's current EPS without NRI is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Goldenwell Biotech stock overvalued right now?
Goldenwell Biotech (GWLL) has a current EPS without NRI of $0.00. The current EPS without NRI is $0.00. Goldenwell Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Goldenwell Biotech (GWLL), the current EPS without NRI is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Goldenwell Biotech Business Description

Address 581 Boston Mills Road, Suite 300, Hudson, OH, USA, 44236
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
30GF Score

Get the complete analysis for GWLL

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price